Target intelligence / Profile preview

RNA, U2 small nuclear 16, pseudogene (RNU2-16P)

Target
RNU2-16P
Molecular classification
Other (Pseudogene), not a receptor, not an enzyme, not a transporter, not a transcription factor, not a true snRNA
01

Overview

RNU2-16P, or RNA, U2 small nuclear 16, pseudogene, is a genomic sequence that closely resembles the gene encoding U2 small nuclear RNA (snRNA), a core component of the spliceosome essential for pre-mRNA splicing[1][2]. However, as a pseudogene, it is generally considered non-functional—typically not transcribed into a mature snRNA and lacking regulatory elements needed for proper expression[3]. While some "pseudogenes" in the U2 snRNA family have recently been found to be expressed and even incorporated into spliceosomes (as in RNU2-2P, now known as an active snRNA)[2], RNU2-16P itself remains annotated as a pseudogene with no evidence of expression, biological activity, or clinical relevance. It is not considered a therapeutic target and does not participate in drug interactions, regulatory mechanisms, or disease pathways. Its classification as a pseudogene means that it does not have biological functions attributed to the canonical U2 snRNA, which is vital for spliceosomal function and pre-mRNA splicing[1][2]. If future research demonstrates functional activity for RNU2-16P, this assessment would need to be revised; at present, it is treated purely as a non-functional, non-coding genomic element.

Other names
RNU2-16PU2 small nuclear RNA pseudogene 16U2 snRNA pseudogene 16

Beyond the preview

Go deeper on RNA, U2 small nuclear 16, pseudogene (RNU2-16P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 16, pseudogene (RNU2-16P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call